These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33398173)

  • 41. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
    Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shared Molecular Mechanisms in Alzheimer's Disease and Amyotrophic Lateral Sclerosis: Neurofilament-Dependent Transport of sAPP, FUS, TDP-43 and SOD1, with Endoplasmic Reticulum-Like Tubules.
    Muresan V; Ladescu Muresan Z
    Neurodegener Dis; 2016; 16(1-2):55-61. PubMed ID: 26605911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.
    Bastow EL; Gourlay CW; Tuite MF
    Biochem Soc Trans; 2011 Oct; 39(5):1482-7. PubMed ID: 21936838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts.
    Onesto E; Colombrita C; Gumina V; Borghi MO; Dusi S; Doretti A; Fagiolari G; Invernizzi F; Moggio M; Tiranti V; Silani V; Ratti A
    Acta Neuropathol Commun; 2016 May; 4(1):47. PubMed ID: 27151080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives.
    Bozzo F; Mirra A; Carrì MT
    Neurosci Lett; 2017 Jan; 636():3-8. PubMed ID: 27150074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
    Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
    Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.
    Xu YF; Gendron TF; Zhang YJ; Lin WL; D'Alton S; Sheng H; Casey MC; Tong J; Knight J; Yu X; Rademakers R; Boylan K; Hutton M; McGowan E; Dickson DW; Lewis J; Petrucelli L
    J Neurosci; 2010 Aug; 30(32):10851-9. PubMed ID: 20702714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From nucleation to widespread propagation: A prion-like concept for ALS.
    Maniecka Z; Polymenidou M
    Virus Res; 2015 Sep; 207():94-105. PubMed ID: 25656065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
    Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals.
    Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M
    Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.
    Audet JN; Soucy G; Julien JP
    Neuroscience; 2012 May; 209():136-43. PubMed ID: 22230045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1
    Ravera S; Bonifacino T; Bartolucci M; Milanese M; Gallia E; Provenzano F; Cortese K; Panfoli I; Bonanno G
    Mol Neurobiol; 2018 Dec; 55(12):9220-9233. PubMed ID: 29656361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
    Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
    Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis.
    Cacabelos D; Ayala V; Granado-Serrano AB; Jové M; Torres P; Boada J; Cabré R; Ramírez-Núñez O; Gonzalo H; Soler-Cantero A; Serrano JC; Bellmunt MJ; Romero MP; Motilva MJ; Nonaka T; Hasegawa M; Ferrer I; Pamplona R; Portero-Otín M
    Neurobiol Dis; 2016 Apr; 88():148-60. PubMed ID: 26805387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control.
    Palomo GM; Manfredi G
    Brain Res; 2015 May; 1607():36-46. PubMed ID: 25301687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.